TORONTO, ON--(NewMediaWire- Feb 16, 2017) - Amfil Technologies
Inc. (OTC
PINK: AMFE) is pleased to give an overview of its GROzone
product line and where it stands today.
GROzone Antimicrobial Systems were originally developed for the
medical marijuana industry as a safer, healthier and more
environmentally friendly alternative to using pesticides and other
harsh cleaning products in cultivation facilities. The GROzone
technology was developed to create and dispense ozone, which is
used as a highly reactive oxidizing agent. When the ozone created
by the system comes in contact with bacteria, the highly reactive
molecules oxidize the pathogen's cell membrane which causes osmotic
bursting, keeping the target areas 99.9% bacteria free.
Last year, two licensed medical marijuana producers in Canada
voluntarily recalled products due to the presence of the prohibited
chemicals myclobutanil, bifenazate and pyrethrins. All of which are
banned for use on cannabis under the Pest Control Products Act
(PCPA). Myclobutanil is a fungicide which is permitted in food
crops, but when burned produces hydrogen cyanide. The human body
can clear low doses of hydrogen cyanide, but in higher doses it can
lead to nausea, vomiting, high blood pressure and increased heart
rates. In rare cases, exposure to hydrogen cyanide can be fatal.
Health Canada made the official recall on January 9, 2017 on nearly
all products sold by a major producer in 2016. Out of the
approximate 120,000 people with a medical marijuana license in
Canada, about 20% were affected by the product recalls. As of
January 31, Health Canada confirmed that they had received a total
of 11 adverse reaction reports, specific to the recalled products.
CBC News has reported that a total of 90 medical marijuana patients
had contacted a class action and medical malpractice law firm with
intention of seeking damages from the producers in question.
In response to all of this, Health Canada has released an
additional statement. The department said, "it will begin random
testing of medical cannabis products produced by licensed
producers, to provide added assurance to Canadians that they are
receiving safe, quality-controlled product," in addition to the
regular unannounced inspections of licensed producer
facilities.
GROzone systems provide a 100% organic alternative to the
pesticides and fungicides which caused the tainted products and
resulting recalls. Had the producers in question been using an
organic alternative such as the GROzone systems, this risk to
public health more than likely could have been avoided. That is not
to mention the loss of product, revenues and brand/industry
reputation.
We intend to continue the campaign and petition Health Canada to
standardize the use of ozone as an antimicrobial substitute for
pesticides and harsh chemicals, especially for any producer
representing their product as "organic".
The GROzone division has been working diligently to gain market
share in the North American sectors, targeting Licensed producers
of cannabis, cannabis extracts, producers of edible products as
well as hydroponic equipment manufacturers and retailers. The
division has been working to finalize a joint venture with a
well-established hydroponic equipment manufacturer, to have the
GROzone technology included with their systems, and also as an
add-on upgrade. We expect to release further details of this
venture in the coming weeks.
Furthermore, the uptrend in home based grow set ups are
increasing, as legalization spreads through North America. The
GROzone division is also creating a smaller scale system, targeting
legal growers with between 0-20 plants. The projected cost of this
set up would be $2,999.00 making it accessible to a larger portion
of the population interested in an organic solution to pesticides
and cleaning supplies.
For more information on GROzone feel free to visit our website
at http://www.amfiltech.com/grozone-1.html or
visit www.grozone.biz
Amfil Technologies Inc. has begun initial discussions regarding
a potential acquisition of an industry related infused vodka, gin
and wine brand. We will be formalizing the discussion by sending an
LOI this week for review. If after the due diligence process is
complete, the company seems to be a good fit, we will make a formal
announcement on the acquisition at that time.
We will be providing an update shortly on the Snakes &
Lagers / Lattes Inc. subsidiary as the expansion plans are
currently underway. We will be addressing topics such as a new
location, new contracts and upcoming events.
Safe Harbor Statement
This news release contains statements that involve expectations,
plans, or intentions (such as those relating to future business or
financial results, new features or services, or management
strategies) and other factors discussed from time to time in the
Company's OTC Market or Securities and Exchange Commission filings.
These statements are forward-looking and are subject to risks and
uncertainties, so actual results may vary materially. You can
identify these forward-looking statements by words such as "may,"
"should," "expect," "anticipate," "believe," "estimate," "intend,"
"plan," and other similar expressions. Our actual results, such as
the Company's ability to finance, market the technology, complete
and consolidate acquisition of IP, assets and operating companies,
could differ materially from those anticipated in these
forward-looking statements as a result of certain factors not
within the control of the company such as a result of various
factors, including future economic, competitive, regulatory, and
market conditions. The company cautions readers not to place undue
reliance on any such forward-looking statements, which speak only
as of the date made. The company disclaims any obligation
subsequently to revise any forward-looking statements to reflect
events or circumstances after the date of such statements or to
reflect the occurrence of anticipated or unanticipated events.